Your Gut Releases Opioid and Blood Pressure-Lowering Peptides When You Digest Milk Protein
Digesting casein protein in healthy humans releases bioactive peptides — including opioid-like β-casomorphins and antihypertensive fragments — in the small intestine at concentrations sufficient to exert biological effects.
Quick Facts
What This Study Found
After ingestion of 30 g of isotope-labeled casein, 356 peptides were detected and sequenced in the jejunum over 6 hours, compared to 146 peptides from whey protein. β-casein was the dominant precursor of bioactive peptides.
Critically, β-casomorphins (β-casein fragments 57-66, with opioid activity) and β-casein 108-113 (with antihypertensive activity) were released at concentrations sufficient to elicit their known biological actions. Casein released medium-sized peptides (750-1050 kDa) continuously over 6 hours, while whey protein released larger peptides (1050-1800 kDa) primarily in the first 3 hours, reflecting their different digestive kinetics.
Key Numbers
How They Did This
Healthy human volunteers (n=13: 7 casein, 6 whey protein) were equipped with double-lumen nasogastric tubes positioned in the proximal jejunum. After ingesting 30 g of nitrogen-15-labeled casein or whey protein, intestinal samples were collected over 6 hours. Nitrogen flow rates were measured, and peptides were identified and sequenced using liquid chromatography-tandem mass spectrometry. The registered clinical trial (NCT00862329) allowed direct characterization of peptides at the site of absorption.
Why This Research Matters
While bioactive peptides from milk have been studied extensively in vitro, proving they actually form in sufficient quantities during human digestion has been a major gap. This study provides direct evidence from the human gut that dairy digestion generates opioid and blood pressure-lowering peptides at biologically meaningful levels, validating the concept that food-derived peptides can have physiological effects beyond basic nutrition.
The Bigger Picture
Food-derived bioactive peptides are a rapidly growing area of nutritional science and functional food development. This study bridges the gap between in vitro peptide discovery and actual human physiology, confirming that the gut is not just absorbing amino acids but also generating peptide signals with opioid, antihypertensive, and potentially other activities. These findings support interest in dairy-derived peptides for functional foods and nutraceuticals targeting blood pressure and gut health.
What This Study Doesn't Tell Us
Small sample size (7 casein, 6 whey protein subjects). The study measured peptide presence in the jejunum but did not directly measure downstream physiological effects (opioid activity, blood pressure changes) in the participants. Nasogastric tube placement may alter normal digestive physiology. The labeled proteins were given in isolation, not as part of a complete meal, which could affect digestive kinetics. Whether these peptides survive further digestion and reach systemic circulation was not assessed.
Questions This Raises
- ?Do the β-casomorphins and antihypertensive peptides detected in the jejunum survive further digestion and reach the bloodstream in active form?
- ?Could regular dairy consumption meaningfully affect blood pressure or opioid signaling through chronic release of these bioactive peptides?
- ?How does consuming dairy as part of a mixed meal (rather than isolated protein) change the peptide release profile?
Trust & Context
- Key Stat:
- 356 peptides from casein Mass spectrometry identified 356 peptides in the human jejunum after casein ingestion, including opioid β-casomorphins and antihypertensive fragments at bioactive concentrations
- Evidence Grade:
- This is a registered human clinical study with direct intestinal sampling, providing strong evidence for peptide formation during digestion. However, the small sample size (n=13), lack of downstream physiological outcome measurement, and single-dose design limit the strength of the conclusions about biological significance.
- Study Age:
- Published in 2013, this was a pioneering study in directly characterizing food-derived peptides in the human gut. The mass spectrometry techniques and findings remain relevant and have been built upon by subsequent research in food peptidomics.
- Original Title:
- Sequential release of milk protein-derived bioactive peptides in the jejunum in healthy humans.
- Published In:
- The American journal of clinical nutrition, 97(6), 1314-23 (2013)
- Authors:
- Boutrou, Rachel, Gaudichon, Claire, Dupont, Didier, Jardin, Julien, Airinei, Gheorghe, Marsset-Baglieri, Agnès, Benamouzig, Robert, Tomé, Daniel, Leonil, Joëlle
- Database ID:
- RPEP-02135
Evidence Hierarchy
Frequently Asked Questions
What are β-casomorphins and why are they significant?
β-casomorphins are short peptide fragments released when your body digests β-casein, a major protein in cow's milk. They have opioid-like activity, meaning they can bind to the same receptors as morphine (though much more weakly). This study showed for the first time that these peptides are released in the human small intestine at concentrations high enough to potentially activate opioid receptors.
Does this mean drinking milk lowers blood pressure?
The study found that digesting casein releases peptides with known antihypertensive (blood pressure-lowering) properties at biologically relevant levels in the gut. However, it did not measure actual blood pressure changes in the participants. Whether these peptides survive further digestion, reach the bloodstream, and produce meaningful blood pressure effects from normal dairy consumption is still an open question.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02135APA
Boutrou, Rachel; Gaudichon, Claire; Dupont, Didier; Jardin, Julien; Airinei, Gheorghe; Marsset-Baglieri, Agnès; Benamouzig, Robert; Tomé, Daniel; Leonil, Joëlle. (2013). Sequential release of milk protein-derived bioactive peptides in the jejunum in healthy humans.. The American journal of clinical nutrition, 97(6), 1314-23. https://doi.org/10.3945/ajcn.112.055202
MLA
Boutrou, Rachel, et al. "Sequential release of milk protein-derived bioactive peptides in the jejunum in healthy humans.." The American journal of clinical nutrition, 2013. https://doi.org/10.3945/ajcn.112.055202
RethinkPeptides
RethinkPeptides Research Database. "Sequential release of milk protein-derived bioactive peptide..." RPEP-02135. Retrieved from https://rethinkpeptides.com/research/boutrou-2013-sequential-release-of-milk
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.